Optimizing In Vivo Delivery & Dosing Strategies to Maximize mRNA Therapeutic Efficacy & Safety
- Comparing systemic vs local delivery strategies for achieving tissue-specific expression
- Examining how lipid type, ionizable components, and dosing schedule impact safety and immunogenicity
- Reviewing preclinical to clinical case studies where formulation or dosing adjustments significantly impacted trial outcomes